BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8833852)

  • 1. Sepsis-enhancing effect of cobalt-60 irradiation in mice infected with virulent Yersinia pestis on the same day or seven days later.
    Wake A; Long PV; Hien HG; Hirota K
    Contrib Microbiol Immunol; 1995; 13():273-6. PubMed ID: 8833852
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogenesis of pestis minor.
    Hirota K; Wake A
    Contrib Microbiol Immunol; 1995; 13():267-72. PubMed ID: 8833851
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic analysis of virulence determinants unique to Yersinia pestis.
    Du Y; Galyov E; Forsberg A
    Contrib Microbiol Immunol; 1995; 13():321-4. PubMed ID: 8833863
    [No Abstract]   [Full Text] [Related]  

  • 4. Construction of defined F1 negative mutants of virulent Yersinia pestis.
    Worsham PL; Stein MP; Welkos SL
    Contrib Microbiol Immunol; 1995; 13():325-8. PubMed ID: 8833864
    [No Abstract]   [Full Text] [Related]  

  • 5. Pathogenesis of Yersinia pestis infection in BALB/c mice: effects on host macrophages and neutrophils.
    Lukaszewski RA; Kenny DJ; Taylor R; Rees DG; Hartley MG; Oyston PC
    Infect Immun; 2005 Nov; 73(11):7142-50. PubMed ID: 16239508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Yersinia pestis lpxM-mutant live vaccine induces enhanced immunity against bubonic plague in mice and guinea pigs.
    Feodorova VA; Pan'kina LN; Savostina EP; Sayapina LV; Motin VL; Dentovskaya SV; Shaikhutdinova RZ; Ivanov SA; Lindner B; Kondakova AN; Bystrova OV; Kocharova NA; Senchenkova SN; Holst O; Pier GB; Knirel YA; Anisimov AP
    Vaccine; 2007 Nov; 25(44):7620-8. PubMed ID: 17913308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional profiling of a mice plague model: insights into interaction between Yersinia pestis and its host.
    Liu H; Wang H; Qiu J; Wang X; Guo Z; Qiu Y; Zhou D; Han Y; Du Z; Li C; Song Y; Yang R
    J Basic Microbiol; 2009 Feb; 49(1):92-9. PubMed ID: 18759226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague.
    Zauberman A; Cohen S; Levy Y; Halperin G; Lazar S; Velan B; Shafferman A; Flashner Y; Mamroud E
    Vaccine; 2008 Mar; 26(13):1616-25. PubMed ID: 18304706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dam mutant of Yersinia pestis is attenuated and induces protection against plague.
    Robinson VL; Oyston PC; Titball RW
    FEMS Microbiol Lett; 2005 Nov; 252(2):251-6. PubMed ID: 16188402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional responses in spleens from mice exposed to Yersinia pestis CO92.
    Rogers JV; Choi YW; Giannunzio LF; Sabourin PJ; Bornman DM; Blosser EG; Sabourin CL
    Microb Pathog; 2007; 43(2-3):67-77. PubMed ID: 17531433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of Yersinia pestis antigens and strains on the level of lymphocyte blast transformation].
    Ledvanov MIu; Emel'ianova NV; Stukova NIu; Shvedun GP; Taranenko TM; Brandzishevskiĭ IuV
    Med Parazitol (Mosk); 1998; (4):25-7. PubMed ID: 10050549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the role of plasminogen activator in systemic infection by virulent Yersinia pestis strain C092.
    Welkos SL; Friedlander AM; Davis KJ
    Microb Pathog; 1997 Oct; 23(4):211-23. PubMed ID: 9344782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Level of macrophages and lymphocytes reacting with nitro-tetrazole blue (NBT) in mice infected with Yersinia enterocolitica].
    Staroniewicz Z
    Med Dosw Mikrobiol; 1993; 45(1):103-6. PubMed ID: 7694016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summary of recent abstracts. VI. Plague.
    Henderson RJ
    Trop Dis Bull; 1970 Jul; 67(7):745-50. PubMed ID: 4922873
    [No Abstract]   [Full Text] [Related]  

  • 15. Persistent survival of attenuated Yersinia pestis organisms with coexistence of chondroitin sulfate colloidal iron within guinea pig macrophages as an initial step of the induction of potent antiplague immunogenesis.
    Iiponen AL; Wake A; Fukaya F
    Contrib Microbiol Immunol; 1991; 12():230-4. PubMed ID: 1935095
    [No Abstract]   [Full Text] [Related]  

  • 16. Characterization of the lipopolysaccharide of Yersinia pestis.
    Prior JL; Hitchen PG; Williamson DE; Reason AJ; Morris HR; Dell A; Wren BW; Titball RW
    Microb Pathog; 2001 Feb; 30(2):49-57. PubMed ID: 11162185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Yersinia pestis factors, assuring circulation and maintenance of the plague pathogen in natural foci ecosystems. Report 1].
    Anisimov AP
    Mol Gen Mikrobiol Virusol; 2002; (3):3-23. PubMed ID: 12243063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental infection of ground squirrels (Citellus pygmaeus Pallas) with Yersinia pestis during hibernation.
    Bizanov G; Dobrokhotova ND
    J Infect; 2007 Feb; 54(2):198-203. PubMed ID: 16580730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE; Butcher WA; Titball RW; Hill J
    Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response.
    Montminy SW; Khan N; McGrath S; Walkowicz MJ; Sharp F; Conlon JE; Fukase K; Kusumoto S; Sweet C; Miyake K; Akira S; Cotter RJ; Goguen JD; Lien E
    Nat Immunol; 2006 Oct; 7(10):1066-73. PubMed ID: 16980981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.